Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Meibohm

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Tuberculosis (Edinburgh, Scotland)|April 30, 2023
Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypesZaid H Temrikar, Sunitha Kodidela, Santosh Kumar, et al.
The AAPS Journal|November 5, 2018
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360Joseph W Polli, Christopher R McCurdy, Dale Eric Wurster, et al.
Free Radical Biology & Medicine|March 6, 2012
Genetic variation in antioxidant enzymes and lung functionAmy R Bentley, Stephen B Kritchevsky, Tamara B Harris, et al.
British Journal of Pharmacology|December 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancerRui Wang, Chun Cai, Shanshan Deng, et al.
Frontiers in Microbiology|September 7, 2018
Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular <i>Mycobacterium tuberculosis</i>Karen Santos, Pradeep B Lukka, Anne Grzegorzewicz, et al.
British Journal of Pharmacology|September 18, 2024
Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase-targeted protein degrader BGB-16673Yue Wu, Bernd Meibohm, Taichang Zhang, et al.
ACS Pharmacology & Translational Science|April 21, 2023
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In VivoSatyanarayana Pochampally, Kelli L Hartman, Rui Wang, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 26, 2014
The challenge of indication extrapolation for infliximab biosimilarsBrian G Feagan, Denis Choquette, Subrata Ghosh, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of TuberculosisSantosh Wagh, Chetan Rathi, Pradeep B Lukka, et al.
ACS Applied Materials & Interfaces|September 26, 2019
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer SenescencePrashanth K B Nagesh, Pallabita Chowdhury, Elham Hatami, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Tuberculosis (Edinburgh, Scotland)|April 30, 2023
Characterization of spectinamide 1599 efficacy against different mycobacterial phenotypesZaid H Temrikar, Sunitha Kodidela, Santosh Kumar, et al.
The AAPS Journal|November 5, 2018
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360Joseph W Polli, Christopher R McCurdy, Dale Eric Wurster, et al.
Free Radical Biology & Medicine|March 6, 2012
Genetic variation in antioxidant enzymes and lung functionAmy R Bentley, Stephen B Kritchevsky, Tamara B Harris, et al.
British Journal of Pharmacology|December 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancerRui Wang, Chun Cai, Shanshan Deng, et al.
Frontiers in Microbiology|September 7, 2018
Primary Lung Dendritic Cell Cultures to Assess Efficacy of Spectinamide-1599 Against Intracellular <i>Mycobacterium tuberculosis</i>Karen Santos, Pradeep B Lukka, Anne Grzegorzewicz, et al.
British Journal of Pharmacology|September 18, 2024
Translational modelling to predict human pharmacokinetics and pharmacodynamics of a Bruton's tyrosine kinase-targeted protein degrader BGB-16673Yue Wu, Bernd Meibohm, Taichang Zhang, et al.
ACS Pharmacology & Translational Science|April 21, 2023
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In VivoSatyanarayana Pochampally, Kelli L Hartman, Rui Wang, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 26, 2014
The challenge of indication extrapolation for infliximab biosimilarsBrian G Feagan, Denis Choquette, Subrata Ghosh, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of TuberculosisSantosh Wagh, Chetan Rathi, Pradeep B Lukka, et al.
ACS Applied Materials & Interfaces|September 26, 2019
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer SenescencePrashanth K B Nagesh, Pallabita Chowdhury, Elham Hatami, et al.
Pageof 18